Search Results

Search by objective public record fields.

Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.

ClinicalTrials.gov public records Last synced May 22, 2026, 3:46 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 25–28 of 4 matching trials from the live ClinicalTrials.gov search.

Local D1 index available.

Filters: Condition: Second Stage Labor Clear all

Recruiting Not applicable Interventional Accepts healthy volunteers

The Role of Oxytocin in the Second Stage of Labor

NCT04303702

View directory record Official record

Conditions: Labor Complication
Interventions: Continue Oxytocin, Discontinue Oxytocin; Drug · Other
Lead sponsor: Washington University School of Medicine; Other
Eligibility: Female only

Enrollment: 400 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: St Louis, Missouri

Source: ClinicalTrials.gov public record

Updated Jan 4, 2026 · Synced May 22, 2026, 3:46 AM EDT

Completed Not applicable Interventional Accepts healthy volunteers Results available

Use of an Occlusal Support Device During the Second Stage of Labor

NCT02807493

View directory record Official record

Conditions: Pregnancy
Interventions: Occlusal Support Device, Control; Device · Other
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years to 40 Years · Female only

Enrollment: 347 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Source: ClinicalTrials.gov public record

Updated Sep 20, 2022 · Synced May 22, 2026, 3:46 AM EDT

Completed Not applicable Interventional Accepts healthy volunteers Results available

Early Initiation of Milk Expression in Mothers of Very Low Birth Weight Infants

NCT01892085

View directory record Official record

Conditions: Breast Milk Expression
Interventions: Early initiation, Intermediate expression, Late initiation; Behavioral
Lead sponsor: University of Florida; Other
Eligibility: 18 Years and older

Enrollment: 180 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: Gainesville, Florida

Source: ClinicalTrials.gov public record

Updated Aug 23, 2023 · Synced May 22, 2026, 3:46 AM EDT

Completed Phase 3 Interventional Results available

A Study to Learn How Well a Higher Amount of Aflibercept Given as an Injection Into the Eye Works and How Safe it is in People With Reduced Vision Due to Swelling in the Macula, Central Part of the Retina Caused by a Blocked Vein in the Retina (Macula Edema Secondary to Retinal Vein Occlusion)

NCT05850520

View directory record Official record

Conditions: Macular Edema Secondary to Retinal Vein Occlusion
Interventions: Aflibercept, VEGF Trap-Eye(Eylea, BAY86-5321)_higher dose, Aflibercept, VEGF Trap-Eye(Eylea, BAY86-5321)_2 mg, Sham, Fluorescein; Drug · Diagnostic Test
Lead sponsor: Bayer; Industry
Eligibility: 18 Years and older

Enrollment: 892 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 53
States / cities: Fullerton, California • Long Beach, California • Mountain View, California + 48 more

Source: ClinicalTrials.gov public record

Updated Dec 17, 2025 · Synced May 22, 2026, 3:46 AM EDT